Health Care/Hospital

PRC-Saltillo Named to Forbes Accessibility 200 List

WOOSTER, Ohio, May 20, 2026 /PRNewswire/ -- PRC-Saltillo has been named to the 2026 Forbes Accessibility 200 list , an annual list r...

2026-05-20 01:38 2097

Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery

Ultra-Fast Protein/Antibody Synthesis in 3 Hours, Speed Up AI-Powered HTP Screening HOUSTON, May 19, 2026 /PRNewswire/ -- Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free ...

2026-05-19 23:45 3530

PartnerOne Launches a Global Philanthropic Initiative to Expand Pediatric Surgical Care in Developing Countries

PartnerOne Global Surgery (POGS) begins with a $10 million commitment from PartnerOne and an inaugural partnership with Montreal Children's Hospital, one of the most renowned pediatric hospitals in the world. RIVERSIDE, Calif., May 19, 2026 /PRNewswire/ -- PartnerOne announced the launch of Part...

2026-05-19 21:00 2088

ALR TECHNOLOGIES HAS LAUNCHED THE GLUCURVE PET CGM IN CANADA

SINGAPORE, May 19, 2026 /PRNewswire/ -- ALR Technologies SG Ltd. ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces the GluCurve Pet CGM ("GluCurve") is now for sale in Canada at www.GluCurve.ca . GluCurve is the first and only diabetic mo...

2026-05-19 20:28 1980

Acemate Launches Drill System, Bringing Scored, Targeted Training to Its AI Tennis System

HONG KONG, May 19, 2026 /PRNewswire/ -- Acemate , the AI-powered tennis training device company backed by OneRobotics (HKG: 6600), today announced its most significant soft...

2026-05-19 19:00 2154

Growth Partner and Docquity Launch Landmark Medically Supervised and Technology-Enabled Umrah Program

Growth Partner and Docquity launch a technology-enabled, doctor-accompanied pilgrimage programme for pilgrims with health conditions — a global first in inclusive Umrah tourism. RIYADH, Saudi Arabia, May 19, 2026 /PRNewswire/ -- Growth Partner and Docquity today announced the launch of the world...

2026-05-19 17:11 2334

Fujitsu, SMBC Group and SoftBank agree on alliance to build Japan-made platform for sustainable healthcare

Companies aim to extend healthy life expectancy, optimize management of healthcare institutions, and curb national healthcare costs Sumitomo Mitsui Financial Group, Inc. Fujitsu Limited SoftBank Corp. TOKYO, May 19, 2026 /PRNewswire/ -- Fujitsu Limited (Fujitsu), Sumitomo Mitsui Financial Group,...

2026-05-19 14:28 2478

BIOTRONIK, Charité, and German Heart Center Foundation Announce Partnership to Advance Digital Cardiology

Strategic Initiative Strengthens Berlin as Europe's Hub of Digital Cardiology BERLIN, May 19, 2026 /PRNewswire/ -- BIOTRONIK, die Charité – Universitätsmedizin Berlin, and the German Heart Center Foundation today announced a research and innovation partnership focused on advancing digital and tr...

2026-05-19 14:00 2424

Caliway Makes First ECO 2026 Oral Presentation on Preclinical Data of CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies, Attracting Strong Interest from International Experts and Global Pharmaceutical Companies for Its Systemic Metabolic Effects

CBL-514, when combined separately with two leading GLP-1R-based weight-loss therapies, semaglutide and tirzepatide, demonstrated enhanced weight loss, attenuated post-discontinuation weight regain, and greater reductions in subcutaneous and visceral fat in animal studies. The presentation also ma...

2026-05-19 13:19 2638

95 years of protecting Singapore: AIA launches AIA Protect 3 to empower the workforce and close critical illness gap

Exclusive to AIA individual and corporate customers and their families, AIA Protect 3 provides multi-stage coverage for cancer, heart attack and stroke — the three most common critical illnesses in Singapore — as a starter or practical critical illness plan SINGAPORE, May 19, 2026 /PRNewswire/ -...

2026-05-19 11:11 913

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Wins Pivotal Phase III Approval, Set to Reshape the Frontline Treatment Landscape for Advanced EP-NEC

NANJING, China, May 18, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that its proprietary PD-L1/4-1BB bispecific antibody, Opamtistomig (LBL-024), has received approval from the Center for Drug Evaluation (CDE) of Chi...

2026-05-19 09:35 2149

Innovent Showcased Clinical and Preclinical Results of Next-Generation Autoimmune and Ophthalmology Pipeline at the 2026 ATS and ARVO Conferences

SAN FRANCISCO and SUZHOU, China, May 18, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...

2026-05-19 08:00 2640

Accro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases

* Financing led by OrbiMed with participation from TCGX, LAV, Cenova Capital and existing investors SCGC and Oriza * Proceeds will advance multi-asset pipeline including AC-101, a leading RIPK2 inhibitor for Ulcerative Colitis NEW YORK and SUZHOU, China, May 18, 2026 /PRNewswire/ -- Accro Bio...

2026-05-19 08:00 2195

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

* IPAX-2 study of TLX101-Tx (¹³¹I-iodofalan) has completed patient enrolment. * Maximum dose reached with no dose-limiting toxicities observed. * TLX101-Tx is also the subject of a pivotal trial, IPAX BrIGHT, which is actively dosing patients with recurrent glioblastoma. MELBOURNE, Australia ...

2026-05-19 05:00 2472

Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Financing

NORWALK, Conn., May 19, 2026 /PRNewswire/ -- Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that improve human healthspan, today announced that it has led Violet Therapeutics' $4.75 million seed extension financing, with participation from Dementia Discovery Fund, UTEC...

2026-05-19 01:03 2050

Millions of 'pandemic pets' are reaching midlife, but owners could miss a crucial opportunity to improve their pet's healthspan

* New global research commissioned by ROYAL CANIN® reveals disconnect in how owners understand their pet's ageing with over a third surveyed (38%) believing nothing can be done about it*, while over half (55%) of those surveyed avoid thinking or talking about their pets ageing because it feels ...

2026-05-18 22:09 2859

Major breakthrough of Sanyou Biopharmaceuticals AI-STAL

SHANGHAI, May 18, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals announced today that its independently developed AI-STAL has undergone a significant upgrade, successfully achieving a qualitative leap from "molecular treasure trove" to "intelligent engine", marking the company's entry into a new ...

2026-05-18 22:00 2707

Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial

- BBT002 is a next-generation, long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-5 - - Preliminary Phase 1 data demonstrated rapid, deep, and sustained effects on key biomarkers for at least 8 weeks following a single dose, including pSTAT6...

2026-05-18 21:15 3336

Piramal Pharma Solutions Announces Partnership with Botanix to Support Drug Substance Development

* Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, to support the development and commercial supply of Sofdra®. * Sofdra is the first and only FDA-approved new chemical entity (NCE) for the treatment of primary axill...

2026-05-18 21:00 2536

MS Pharma Announces Strategic Growth Investment from Olayan Financing Company

Strategic Partnership to Accelerate Growth in Saudi Arabia and Across the MENA Region AMMAN, Jordan and RIYADH, Saudi Arabia, May 18, 2026 /PRNewswire/ -- MS Pharma today announced that Olayan Financing Company (OFC) has made a minority equity investment in the company. This partnership brings s...

2026-05-18 20:39 1911
12345 ... 859